search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
PRESENTING THE FUTURE


Air Force Lt. Col. Melinda Eaton, director of strategic acquisition plan- ning and program management, prepares for a presentation on the work of USAMMDA’s Combat Trauma and Acute Rehabilitation Proj- ect Management Office, which supports research efforts in such areas as vascular repair and burn treatment. Eaton also serves as government program manager for ARMI’s BioFabUSA project, a DOD-funded effort to enable large-scale biological manufacturing. (Photo by Ashley Force, USAMMDA Public Affairs)


BRAIN BLOOD TEST


Veronika Shevchenko, center, research scientist with industry partner Banyan Biomarkers Inc., leads a training session to demonstrate the Laboratory Assay for Traumatic Brain Injury at Fort Detrick in March 2018. The device tests blood for biomarkers released upon injury to the brain and can help diagnose post-traumatic stress disorder. (Photo by Jeffrey M. Soares, USAMMDA Public Affairs)


she said. “For example, we know we have unique wounds from the battlefield that they may not see in the civilian sector, and this could be very helpful to their own research.”


CONCLUSION It would be hard to diminish the value of industry partnerships or the open campus concept, especially in light of the recent success of tafenoquine as the first FDA-approved malaria drug in nearly two decades. Te idea of collaboration is infused throughout the important work of USAMMDA and the collective mission of all involved.


Army Col. Ryan Bailey, USAMMDA commander, has been immersed in military medical product development since assum- ing command of the organization in 2017. He recognizes the true value of industry partnerships for success in these unique endeavors.


“Tese types of partnerships are not about multiple teams racing toward a finish line, hoping to jump ahead of each other in the final stretch,” he said. “Te concept is more like a relay race, where talented individuals work closely together to reach the goal, doing


everything possible to ensure the team does not ‘drop the baton’ along the way.”


Although the BioFabUSA project may have a great deal to prove in the future, the prospects are exciting. In working with an extensive list of partners, it is likely that many good things will come from such synergistic relationships. For this important effort, restoring wounded service members and civilians to form, function and appearance remains paramount—and the possibil- ities through effective partnerships remain endless.


For more information on the work and mission of USAMMDA, go to http://www.usammda.army.mil/.


JEFFREY M. SOARES is a senior technical writer and communi- cations specialist with General Dynamics Information Technology, providing contract support as chief writer for the Public Affairs Office and Office of the Commander at USAMMDA. He holds an M.A. in English language and literature from the University of Mary- land, College Park and a B.S. in education with a concentration in English from the University of Scranton.


HTTPS: / /ASC.ARMY.MIL


65


SCIENCE & TECHNOLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152